Boram Kim

2 months ago | onlinelibrary.wiley.com | Min-Seung Park |Boram Kim |Hyun-Young Kim |Chul Won Jung

Please review our Terms and Conditions of Use and check box below to share full-text version of article. I have read and accept the Wiley Online Library Terms and Conditions of UseUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.

Jan 21, 2025 | digitalcommons.library.tmc.edu | Maria Chen |Boram Kim |Maria Jarvis |Samantha T. Fleury

KeywordsAnimals, Mice, Dependovirus, Gene Transfer Techniques, Genetic Therapy, Immunoglobulin M, Genetic Vectors, Adeno-associated viruses, Vectors, Gene delivery, Immunotherapy, Blood-brain barrier, Brain delivery, ImmunogenicityAbstractAdeno-associated virus (AAV) vector-based gene therapies can be applied to a wide range of diseases. AAV expression can last for months to years, but vector re-administration may be necessary to achieve life-long treatment.

Oct 11, 2024 | pubs.rsc.org | Boram Kim |Martha Fowler |Claire Yang |Joseph W Swain

Rapid method to screen biomaterial angiogenesis in vivo using fluorescence imaging in mice Effective vascularization is crucial for repairing and enhancing the longevity of engineered tissues and organs. As the field advances, there is a vital need for efficient and reliable methods for assessing vascularization in real-time.

Jul 19, 2024 | medrxiv.org | Boram Kim |Holly Elser |Sharon Xie |Kaitlin Blam

EBL serves as a paid consultant to Wavebreak Therapeutics. DAW has served as a paid consultant to Eli Lilly, GE Healthcare, and Qynapse. DAW serves on a DSMB for Functional Neuromodulation and GSK. DAW receives research support paid to his institution from Biogen. TMP is founder of Penzymes, LLC; he is a consultant for Propella therapeutics and member of the Expert Panel for the Research Institute of Fragrance Materials. All other authors declare no competing interests.

Jan 25, 2024 | mdpi.com | Mostafizur Rahman |Tuan Nguyen |Gi Jeong Lee |Boram Kim

All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.